|
1
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, Lu R, et al: China Novel Coronavirus
Investigating and Research Team: A Novel Coronavirus from Patients
with Pneumonia in China, 2019. N Engl J Med. 382:727–733. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu J, Zhao S, Teng T, Abdalla AE, Zhu W,
Xie L, Wang Y and Guo X: Systematic comparison of two
animal-to-human trans-mitted human Coronaviruses: SARS-CoV-2 and
SARS-CoV. Viruses. 12:122020. View Article : Google Scholar
|
|
3
|
Cucinotta D and Vanelli M: WHO Declares
COVID-19 a Pandemic. Acta Biomed. 91:157–160. 2020.PubMed/NCBI
|
|
4
|
Chen L, Jin Q, Zhou Y, Yang J, Wang Z, Ge
K, Yang J and Wang H: Clinical characteristics of 2019 novel
coronavirus pneumonia in Zhejiang province, China. Mol Med Rep.
22:2583–2587. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanduc D and Shoenfeld Y: On the molecular
determinants of the SARS-CoV-2 attack. Clin Immunol.
215:1084262020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He J, Guo Y, Mao R and Zhang J: Proportion
of asymptomatic coronavirus disease 2019 (COVID-19): A systematic
review and meta-analysis. J Med Virol. jmv263262020. View Article : Google Scholar
|
|
7
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han
Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: A descriptive study. Lancet. 395:507–513. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Docea AO, Tsatsakis A, Albulescu D,
Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou
M, Drakoulis N, et al: A new threat from an old enemy: Re-emergence
of coronavirus (Review). Int J Mol Med. 45:1631–1643.
2020.PubMed/NCBI
|
|
9
|
Kostoff RN, Briggs MB, Porter AL, Aschner
M, Spandidos DA and Tsatsakis A: [Editorial] COVID-19:
Post-lockdown guidelines. Int J Mol Med. 46:463–466. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shoenfeld Y: Corona (COVID-19) time
musings: Our involvement in COVID-19 pathogenesis, diagnosis,
treatment and vaccine planning. Autoimmun Rev. 19:1025382020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mehta P, McAuley DF, Brown M, Sanchez E
and Tattersall RS: COVID-19: Consider cytokine storm syndromes and
immuno-suppression. Lancet. 395:1033–1034. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stancioiu F, Papadakis GZ, Kteniadakis S,
Izotov BN, Coleman MD, Spandidos DA and Tsatsakis A: A dissection
of SARS-CoV-2 with clinical implications (Review). Int J Mol Med.
46:489–508. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kerslake R, Hall M, Randeva HS, Spandidos
DA, Chatha K, Kyrou I and Karteris E: Co-expression of peripheral
olfactory receptors with SARS-CoV-2 infection mediators: Potential
implications beyond loss of smell as a COVID-19 symptom. Int J Mol
Med. 46:949–956. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang N, Li D, Wang X and Sun Z: Abnormal
coagulation parameters are associated with poor prognosis in
patients with novel coronavirus pneumonia. J Thromb Haemost.
18:844–847. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruscitti P, Berardicurti O, Di Benedetto
P, Cipriani P, Iagnocco A, Shoenfeld Y and Giacomelli R: Severe
COVID-19, Another Piece in the Puzzle of the Hyperferritinemic
Syndrome. An Immunomodulatory Perspective to Alleviate the Storm.
Front Immunol. 11:11302020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Perricone C, Bartoloni E, Bursi R, Cafaro
G, Guidelli GM, Shoenfeld Y and Gerli R: COVID-19 as part of the
hyperferritinemic syndromes: The role of iron depletion therapy.
Immunol Res. 68:213–224. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blanco-Melo D, Nilsson-Payant BE, Liu WC,
Møller R, Panis M, Sachs D and Albrecht RA: tenOever BR:SARS-CoV-2
launches a unique transcriptional signature from in vitro, ex vivo,
and in vivo systems. bioRxiv: https://doi.org/10.1101/2020.03.24.004655.
|
|
18
|
Fagone P, Ciurleo R, Lombardo SD,
Iacobello C, Palermo CI, Shoenfeld Y, Bendtzen K, Bramanti P and
Nicoletti F: Transcriptional landscape of SARS-CoV-2 infection
dismantles pathogenic pathways activated by the virus, proposes
unique sex-specific differences and predicts tailored therapeutic
strategies. Autoimmun Rev. 19:1025712020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou Y, Zhou B, Pache L, Chang M,
Khodabakhshi AH, Tanaseichuk O, Benner C and Chanda SK: Metascape
provides a biologist-oriented resource for the analysis of
systems-level datasets. Nat Commun. 10:15232019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aran D, Hu Z and Butte AJ: xCell:
Digitally portraying the tissue cellular heterogeneity landscape.
Genome Biol. 18:2202017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheng Y, Luo R, Wang K, Zhang M, Wang Z,
Dong L, Li J, Yao Y, Ge S and Xu G: Kidney disease is associated
with in-hospital death of patients with COVID-19. Kidney Int.
97:829–838. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K,
Yang L, Liu C and Yang C: Nervous system involvement after
infection with COVID-19 and other coronaviruses. Brain Behav Immun.
87:18–22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han H, Yang L, Liu R, Liu F, Wu KL, Li J,
Liu XH and Zhu CL: Prominent changes in blood coagulation of
patients with SARS-CoV-2 infection. Clin Chem Lab Med.
58:1116–1120. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cavalli E, Bramanti A, Ciurleo R,
Tchorbanov AI, Giordano A, Fagone P, Belizna C, Bramanti P,
Shoenfeld Y and Nicoletti F: Entangling COVID-19 associated
thrombosis into a secondary antiphospholipid antibody syndrome:
Diagnostic and therapeutic perspectives (Review). Int J Mol Med.
46:903–912. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ehrenfeld M, Tincani A, Andreoli L,
Cattalini M, Greenbaum A, Kanduc D, Alijotas-Reig J, Zinserling V,
Semenova N, Amital H, et al: Covid-19 and autoimmunity. Autoimmun
Rev. 19:1025972020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Xiao M, Zhang S, Xia P, Cao W,
Jiang W, Chen H, Ding X, Zhao H, Zhang H, et al: Coagulopathy and
antiphos-pholipid antibodies in patients with Covid-19. N Engl J
Med. 382:e382020. View Article : Google Scholar
|
|
27
|
Beyrouti R, Adams ME, Benjamin L, Cohen H,
Farmer SF, Goh YY, Humphries F, Jäger HR, Losseff NA, Perry RJ, et
al: Characteristics of ischaemic stroke associated with COVID-19. J
Neurol Neurosurg Psychiatry. 91:889–891. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harzallah I, Debliquis A and Drenou B:
Lupus anticoagulant is frequent in patients with Covid-19. J Thromb
Haemost. 18:2064–2065. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zayet S, Klopfenstein T, Kovacs R,
Stancescu S and Hagenkötter B: Acute cerebral stroke with multiple
infarctions and COVID-19, France, 2020. Emerg Infect Dis.
26:262020. View Article : Google Scholar
|
|
30
|
Helms J, Tacquard C, Severac F,
Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R,
Schenck M, Fagot Gandet F, et al: CRICS TRIGGERSEP Group (Clinical
Research in Intensive Care and Sepsis Trial Group for Global
Evaluation and Research in Sepsis): High risk of thrombosis in
patients with severe SARS-CoV-2 infection: A multicenter
prospective cohort study. Intensive Care Med. 46:1089–1098. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sieiro Santos C, Nogal Arias C, Moriano
Morales C, Ballesteros Pomar M, Diez Alvarez E and Perez Sandoval
T: Antiphospholipid antibodies in patient with acute lower member
ischemia and pulmonary thromboembolism as a result of infection by
SARS-CoV2. Clin Rheumatol. 39:2105–2106. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fagone P, Mangano K, Quattrocchi C,
Motterlini R, Di Marco R, Magro G, Penacho N, Romao CC and
Nicoletti F: Prevention of clinical and histological signs of
proteolipid protein (PLP)-induced experimental allergic
encephalomyelitis (EAE) in mice by the water-soluble carbon
monoxide-releasing molecule (CORM)-A1. Clin Exp Immunol.
163:368–374. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fagone P, Mangano K, Coco M, Perciavalle
V, Garotta G, Romao CC and Nicoletti F: Therapeutic potential of
carbon monoxide in multiple sclerosis. Clin Exp Immunol.
167:179–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cavalli E, Mazzon E, Basile MS, Mangano K,
Di Marco R, Bramanti P, Nicoletti F, Fagone P and Petralia MC:
Upregulated expression of macrophage migration inhibitory factor,
its analogue D-Dopachrome Tautomerase, and the CD44 receptor in
peripheral CD4 T cells from clinically isolated syndrome patients
with rapid conversion to clinical defined multiple sclerosis.
Medicina (Kaunas). 55:6672019. View Article : Google Scholar
|
|
35
|
Rothweiler F, Michaelis M, Brauer P, Otte
J, Weber K, Fehse B, Doerr HW, Wiese M, Kreuter J, Al-Abed Y, et
al: Anticancer effects of the nitric oxide-modified saquinavir
derivative saquinavir-NO against multidrug-resistant cancer cells.
Neoplasia. 12:1023–1030. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nicoletti F, Fagone P, Meroni P, McCubrey
J and Bendtzen K: mTOR as a multifunctional therapeutic target in
HIV infection. Drug Discov Today. 16:715–721. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lombardo SD, Mazzon E, Basile MS, Cavalli
E, Bramanti P, Nania R, Fagone P, Nicoletti F and Petralia MC:
Upregulation of IL-1 receptor antagonist in a mouse model of
migraine. Brain Sci. 9:1722019. View Article : Google Scholar :
|
|
38
|
Petralia MC, Mazzon E, Fagone P, Falzone
L, Bramanti P, Nicoletti F and Basile MS: Retrospective follow-up
analysis of the transcriptomic patterns of cytokines, cytokine
receptors and chemokines at preconception and during pregnancy, in
women with post-partum depression. Exp Ther Med. 18:2055–2062.
2019.PubMed/NCBI
|
|
39
|
Lombardo SD, Mazzon E, Mangano K, Basile
MS, Cavalli E, Mammana S, Fagone P, Nicoletti F and Petralia MC:
Transcriptomic analysis reveals involvement of the macrophage
migration inhibitory factor gene network in Duchenne Muscular
Dystrophy. Genes (Basel). 10. pp. 9392019, View Article : Google Scholar
|
|
40
|
Kosiewicz MM, Auci DL, Fagone P, Mangano
K, Caponnetto S, Tucker CF, Azeem N, White SK, Frincke JM, Reading
CL, et al: HE3286, an orally bioavailable synthetic analogue of an
active DHEA metabolite suppresses spontaneous autoimmune diabetes
in the non-obese diabetic (NOD) mouse. Eur J Pharmacol.
658:257–262. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lombardo SD, Presti M, Mangano K, Petralia
MC, Basile MS, Libra M, Candido S, Fagone P, Mazzon E, Nicoletti F,
et al: Prediction of PD-L1 expression in neuroblastoma via
computational modeling. Brain Sci. 9:2212019. View Article : Google Scholar :
|
|
42
|
Basile MS, Mazzon E, Russo A, Mammana S,
Longo A, Bonfiglio V, Fallico M, Caltabiano R, Fagone P, Nicoletti
F, et al: Differential modulation and prognostic values of
immuneescape genes in uveal melanoma. PLoS One. 14:e02102762019.
View Article : Google Scholar
|
|
43
|
Vabret N, Britton GJ, Gruber C, Hegde S,
Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, et al:
Sinai Immunology Review Project: Immunology of COVID-19: Current
State of the Science. Immunity. 52:910–941. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bao L, Deng W, Gao H, Xiao C, Liu J, Xue
J, Lv Q, Liu J, Yu P, Xu Y, et al: Reinfection could not occur in
SARS-CoV-2 infected rhesus macaques. bioRxiv: https://doi.org/10.1101/2020.03.13990226.
|
|
45
|
Okba NMA, Müller MA, Li W, Wang C, Geurts
van Kessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E,
Chandler FD, et al: Severe acute respiratory syndrome coronavirus
2-specific antibody responses in coronavirus disease patients.
Emerg Infect Dis. 26:1478–1488. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su
Y, Wang X, Yuan J, Li T, Li J, et al: Antibody responses to
SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin
Infect Dis. March 28–2020.Epub ahead of print. View Article : Google Scholar
|
|
47
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retro-spective cohort study. Lancet. 395:1054–1062. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tetro JA: Is COVID-19 receiving ADE from
other coronaviruses? Microbes Infect. 22:72–73. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cao X: COVID-19: Immunopathology and its
implications for therapy. Nat Rev Immunol. 20:269–270. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Iwasaki A and Yang Y: The potential danger
of suboptimal antibody responses in COVID-19. Nat Rev Immunol.
20:339–341. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Huang A, Garcia-Carreras B, Hitchings M,
Yang B, Katzelnick LC, Rattigan SM, Borgert BA, Moreno CA, Solomon
BD, Rodriguez-Barraquer I, et al: A systematic review of antibody
mediated immunity to coronaviruses: antibody kinetics, correlates
of protection, and association of antibody responses with severity
of disease. medRxiv. View Article : Google Scholar
|
|
52
|
Zheng Y, Li R and Liu S: Immunoregulation
with mTOR inhibitors to prevent COVID-19 severity: A novel
intervention strategy beyond vaccines and specific antiviral
medicines. J Med Virol. May 22–2020.Epub ahead of print.
|
|
53
|
Raybuck AL, Cho SH, Li J, Rogers MC, Lee
K, Williams CL, Shlomchik M, Thomas JW, Chen J, Williams JV, et al:
B cell-intrinsic mTORC1 promotes germinal center-defining
transcription factor gene expression, somatic hypermutation, and
memory B cell generation in humoral immunity. J Immunol.
200:2627–2639. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kindrachuk J, Ork B, Hart BJ, Mazur S,
Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH,
et al: Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling
modulation for Middle East respiratory syndrome coronavirus
infection as identified by temporal kinome analysis. Antimicrob
Agents Chemother. 59:1088–1099. 2015. View Article : Google Scholar :
|
|
55
|
Kuss-Duerkop SK, Wang J, Mena I, White K,
Metreveli G, Sakthivel R, Mata MA, Muñoz-Moreno R, Chen X, Krammer
F, et al: Influenza virus differentially activates mTORC1 and
mTORC2 signaling to maximize late stage replication. PLoS Pathog.
13:e10066352017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Nicoletti F, Lapenta C, Donati S, Spada M,
Ranazzi A, Cacopardo B, Mangano K, Belardelli F, Perno C and Aquaro
S: Inhibition of human immunodeficiency virus (HIV-1) infection in
human peripheral blood leucocytes - SCID reconstituted mice by
rapamycin. Clin Exp Immunol. 155:28–34. 2009. View Article : Google Scholar :
|
|
57
|
Donia M, McCubrey JA, Bendtzen K and
Nicoletti F: Potential use of rapamycin in HIV infection. Br J Clin
Pharmacol. 70:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang CH, Chung FT, Lin SM, Huang SY, Chou
CL, Lee KY, Lin TY and Kuo HP: Adjuvant treatment with a mammalian
target of rapamycin inhibitor, sirolimus, and steroids improves
outcomes in patients with severe H1N1 pneumonia and acute
respiratory failure. Crit Care Med. 42:313–321. 2014. View Article : Google Scholar
|
|
59
|
Cai H: Sex difference and smoking
predisposition in patients with COVID-19. Lancet Respir Med.
8:e202020. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Li L, Huang T and Wang Y, Wang ZP, Liang
Y, Huang TB, Zhang HY, Sun W and Wang Y: COVID-19 patients'
clinical characteristics, discharge rate, and fatality rate of
meta-analysis. J Med Virol. 92:577–583. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lai JJ, Lai KP, Zeng W, Chuang KH,
Altuwaijri S and Chang C: Androgen receptor influences on body
defense system via modulation of innate and adaptive immune
systems: Lessons from conditional AR knockout mice. Am J Pathol.
181:1504–1512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gubbels Bupp MR and Jorgensen TN:
Androgen-induced immunosuppression. Front Immunol. 9:7942018.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kovats S: Estrogen receptors regulate
innate immune cells and signaling pathways. Cell Immunol.
294:63–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Zhou Y, Hou Y, Shen J, Huang Y, Martin W
and Cheng F: Network-based drug repurposing for novel coronavirus
2019-nCoV/SARS-CoV-2. Cell Discov. 6:142020. View Article : Google Scholar : PubMed/NCBI
|
